|
Global Common Cold Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Coronary Artery Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global COPD Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Renal Failure Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Gynecology Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
300 |
Global |
$2,995.00 |
|
|
Global Anthrax Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Liver Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Glaucoma Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Neuralgia Partnering 2012-2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Animal Health Partnering Terms and Agreements 2012 to 2018 |
Sep 1 2018 |
306 |
Global |
$1,995.00 |
|
|
Global Tuberculosis Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Hypercholesterolemia Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Learning Disability Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Huntington's Disease Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Genetic disorders Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
500 |
Global |
$2,995.00 |
|
|
Global Head and Neck Cancer Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Psychiatry Partnering 2012-2018: Deal trends, players and financials |
Sep 1 2018 |
700 |
Global |
$2,995.00 |
|
|
Global Prenatal Screening Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
Global Stroke Partnering 2012 to 2018 |
Sep 1 2018 |
150 |
Global |
$1,995.00 |
|
|
Global Infectious Vaccines Partnering Terms and Agreements 2012 to 2018: Deal trends, players and financials |
Sep 1 2018 |
457 |
Global |
$2,995.00 |
|
|
Global AIDS Partnering 2012 to 2018 |
Sep 1 2018 |
100 |
Global |
$1,995.00 |
|
|
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players |
May 4 2018 |
140 |
Global |
$2,995.00 |
|
|
Acne Vulgaris - Epidemiology Forecast to 2026 |
Mar 1 2018 |
37 |
Global |
$3,995.00 |
|
|
OpportunityAnalyzer: Late - Stage Chronic Kidney Disease - Opportunity Analysis and Forecasts to 2026 |
Dec 31 2017 |
195 |
Global |
$10,995.00 |
|
|
PharmaPoint: Irritable Bowel Syndrome (IBS) - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
185 |
Global |
$10,995.00 |
|
|
PharmaPoint: Glaucoma - Global Drug Forecast and Market Analysis to 2026 |
Dec 20 2017 |
280 |
Global |
$10,995.00 |
|
|
Global Attention Deficit Disorder Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Nektar Therapeutics Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Regenerative Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
717 |
Global |
$2,995.00 |
|
|
Global Personalized Medicine Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
1000 |
Global |
$3,495.00 |
|
